(720 ILCS 570/205) (from Ch. 56 1/2, par. 1205)
    Sec. 205. The Department, taking into consideration the recommendations of its Prescription Monitoring Program Advisory Committee, may issue a rule scheduling a substance in Schedule II if it finds that:
        (1) the substance has high potential for misuse;
        (2) the substance has currently accepted medical use
    
in treatment in the United States, or currently accepted medical use with severe restrictions; and
        (3) the misuse of the substance may lead to severe
    
psychological or physiological dependence.
(Source: P.A. 103-881, eff. 1-1-25.)